Abstract
Pharmacogenetic prediction and mechanistic elucidation of individual variations of drug response is important for facilitating the development of personalized medicines and optimum therapeutic dosages. One of the keys to pharmacogenetic studies is the knowledge about proteins responsible for the absorption, distribution, metabolism and excretion (ADME) of drugs. This article describes the web-resources of ADME-associated proteins, assesses the usefulness of the relevant information for facilitating pharmacogenetic prediction of drug responses, and discusses computational methods that explore the relevant information for predicting individual variations of drug response from the polymorphisms of ADME-associated proteins.
Keywords: Carrier, drug design, drug development, drug discovery, drug metabolizing enzyme, drug target, ligand-binding protein, pharmacokinetics, pharmacogenomics, pharmacogenetics
Current Pharmacogenomics
Title: Information of ADME-Associated Proteins and Potential Application for Pharmacogenetic Prediction of Drug Responses
Volume: 4 Issue: 2
Author(s): C. J. Zheng, L. Y. Han, X. Chen, Z. W. Cao, J. Cui, H. H. Lin, H. L. Zhang, H. Li and Y. Z. Chen
Affiliation:
Keywords: Carrier, drug design, drug development, drug discovery, drug metabolizing enzyme, drug target, ligand-binding protein, pharmacokinetics, pharmacogenomics, pharmacogenetics
Abstract: Pharmacogenetic prediction and mechanistic elucidation of individual variations of drug response is important for facilitating the development of personalized medicines and optimum therapeutic dosages. One of the keys to pharmacogenetic studies is the knowledge about proteins responsible for the absorption, distribution, metabolism and excretion (ADME) of drugs. This article describes the web-resources of ADME-associated proteins, assesses the usefulness of the relevant information for facilitating pharmacogenetic prediction of drug responses, and discusses computational methods that explore the relevant information for predicting individual variations of drug response from the polymorphisms of ADME-associated proteins.
Export Options
About this article
Cite this article as:
Zheng J. C., Han Y. L., Chen X., Cao W. Z., Cui J., Lin H. H., Zhang L. H., Li H. and Chen Z. Y., Information of ADME-Associated Proteins and Potential Application for Pharmacogenetic Prediction of Drug Responses, Current Pharmacogenomics 2006; 4 (2) . https://dx.doi.org/10.2174/157016006776286819
DOI https://dx.doi.org/10.2174/157016006776286819 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Current Pediatric Reviews Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review
Mini-Reviews in Medicinal Chemistry Placental Drug Disposition and Its Clinical Implications
Current Drug Metabolism Brain Hyperthermia During Physiological and Pathological Conditions: Causes, Mechanisms, and Functional Implications
Current Neurovascular Research tPA in the Central Nervous System: Relations Between tPA and Cell Surface LRPs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) NMDA Receptor Pharmacology: Perspectives from Molecular Biology
Current Drug Targets Distinct Forms of Spinal Cysticercosis: A Vietnamese Case Series
Current Medical Imaging HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Current Pharmaceutical Design Clinical Trials for Neuroprotection in ALS
CNS & Neurological Disorders - Drug Targets A New Class of Anticonvulsants Possessing 6 Hz Psychomotor Seizure Test Activity: 2-(1H-Benzotriazol-1-yl)-N'-[Substituted] Acetohydrazides
Medicinal Chemistry Drug Therapy for Patients with Eating Disorders
Current Drug Targets - CNS & Neurological Disorders Spirooxindoles as Potential Pharmacophores
Mini-Reviews in Medicinal Chemistry Trends in Utilization of the Pharmacological Potential of Chalcones
Current Clinical Pharmacology Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction
Current Pharmaceutical Design Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I
Anti-Cancer Agents in Medicinal Chemistry Supercritical Extraction of Heracleum persicum Plant and Mathematical Modeling
The Natural Products Journal Epilepsy, Theories and Treatment Inside Corpus Hippocraticum
Current Pharmaceutical Design Serum Thiol-Disulphide Levels in Epileptic Pediatric Patients
Combinatorial Chemistry & High Throughput Screening Search and Rescue: Identification of Cannabinoid Actions Relevant for Neuronal Survival and Protection
Current Neuropharmacology Endocannabinoid System: A Multi-Facet Therapeutic Target
Current Clinical Pharmacology